1194044-20-6 Usage
Description
LY2811376 is a pharmaceutical compound that has been found to decrease the production of β-amyloid peptide (Aβ) associated with the cleavage of amyloid precursor protein (APP) by β-secretase (BACE) and γ-secretase. This decrease is significant as it is hypothesized that the build-up of Aβ in the brain is a primary cause of neurodegeneration and Alzheimer's disease progression.
Uses
Used in Pharmaceutical Industry:
LY2811376 is used as a potential therapeutic agent for the treatment of Alzheimer's disease. Its ability to decrease the production of β-amyloid peptide (Aβ) makes it a promising candidate for managing the neurodegeneration and progression of Alzheimer's.
Used in Neurodegenerative Research:
In the field of neurodegenerative research, LY2811376 is used as a research tool to study the role of Aβ in Alzheimer's disease and to develop new therapeutic strategies targeting the underlying mechanisms of neurodegeneration.
Check Digit Verification of cas no
The CAS Registry Mumber 1194044-20-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,4,0,4 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1194044-20:
(9*1)+(8*1)+(7*9)+(6*4)+(5*0)+(4*4)+(3*4)+(2*2)+(1*0)=136
136 % 10 = 6
So 1194044-20-6 is a valid CAS Registry Number.
InChI:InChI=1S/C15H14F2N4S/c1-15(2-3-22-14(18)21-15)11-4-10(12(16)5-13(11)17)9-6-19-8-20-7-9/h4-8H,2-3H2,1H3,(H2,18,21)/t15-/m0/s1
